BPW
GILD icon

Bingham Private Wealth’s Gilead Sciences GILD Stock Holding History

Bingham Private Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.51M Buy
11,946
+21
+0.2% +$2.77K 1.04% 23
2026
Q1 		$1.66M Buy
11,925
+395
+3% +$55.3K 1.32% 15
2025
Q4 		$1.42M Buy
+11,530
New +$1.4M 1.22% 21
2025
Q2 		$1.3M Buy
11,688
+17
+0.1% +$1.81K 1.24% 19
2025
Q1 		$1.31M Sell
11,671
-331
-3% -$34.2K 1.35% 18
2024
Q4 		$1.11M Buy
+12,002
New +$1.08M 1.18% 21

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bingham Private Wealth's GILD Position: Q2 2026 in Review

Bingham Private Wealth increased its Gilead Sciences (GILD) stake by 0.18% in Q2 2026, buying an estimated $2.77K and bringing the position to 11,946 shares worth $1.51M. The position accounts for 1.04% of the portfolio, ranked #23.

Bingham Private Wealth first reported a position in GILD in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.66M in Q1 2026. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Bingham Private Wealth held 11,946 shares of Gilead Sciences worth $1.51M as of Q2 2026.
  • Bingham Private Wealth bought 21 Gilead Sciences shares in Q2 2026, an estimated $2.77K.
  • Gilead Sciences made up 1.04% of Bingham Private Wealth's portfolio in Q2 2026, its #23 holding.
  • Bingham Private Wealth first reported a position in Gilead Sciences in Q4 2024 and has held it in 6 quarters since.
  • Bingham Private Wealth's Gilead Sciences position peaked at $1.66M in Q1 2026.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Bingham Private Wealth's 13F filing for Q2 2026, filed 11 Aug 2026.